Diagnosis and treatment of rare genetic diseases
Rare genetic diseases affect approximately 3.5 million people in the UK. How can genetic technologies, policies and initiatives in healthcare support diagnosis and treatment?
Rare genetic diseases affect approximately 3.5 million people in the UK. How can genetic technologies, policies and initiatives in healthcare support diagnosis and treatment?
Winter mortality in the UK is higher than in some colder European countries. How are deaths during winter monitored, and what evidence exists for interventions to prevent these deaths?
Orphan drugs are drugs used to treat rare diseases. In April 2025, NICE adopted new criteria for evaluating drugs for ‘ultra rare’ diseases.
Horizon scanning
Climate change has implications for the health of UK citizens. How prepared are health and care systems?
POSTnote
This POSTnote summarises the challenges and opportunities relating to the production, regulation and consumption of cultivated meat, also known as 'lab grown' meat.
POSTbrief
Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.
Horizon scanning
Healthy diets would improve population-wide health and reduce wider health inequalities but are unaffordable for the poorest 20% of the population.